Judge: Investors Cite Only Opinions, Not Falsehoods, In Medical Stock Drop Suit

(August 6, 2024, 11:18 AM EDT) -- NEW YORK — A federal judge in New York granted a pharmaceutical company’s motion to dismiss a putative class complaint brought against it by investors who claimed the company and certain of its executives issued misleading statements about a drug it was developing for a kidney disease; the judge found that “nearly every one” of the statements cited by the investors was an unactionable forward-looking statement....

Attached Documents

Related Sections